Surgical Model Of Osteoarthritis Research Articles

Pilot comparison of outcome measures across chemical and surgical experimental models of chronic osteoarthritis in the rat (Rattus norvegicus).

Relatively little work has evaluated both the disease of osteoarthritis (OA) and clinically-relevant pain outcome measures across different OA models in rats. The objective of this study was to compare sensitivity, pain, and histological disease severity across chemical and surgical models of OA in the rat. Stifle OA was induced in Sprague-Dawley rats via intraarticular injection of monoiodoacetate (MIA) or surgical transection of anterior cruciate ligament and/or destabilization of medial meniscus (ACL+DMM or DMM alone). Reflexive (e.g., mechanical and thermal stimuli) measures of sensitivity and non-reflexive assays (e.g., lameness, static hindlimb weight-bearing asymmetry, dynamic gait analysis) of pain were measured over time. Joint degeneration was assessed histologically. Six-weeks post OA-induction, the ACL+DMM animals had significantly greater visually observed lameness than MIA animals; however, both ACL+DMM and MIA animals showed equal pain as measured by limb use during ambulation and standing. The MIA animals showed increased thermal, but not mechanical, sensitivity compared to ACL+DMM animals. Joint degeneration was significantly more severe in the MIA model at 6 weeks. Our pilot data suggest both the ACL+DMM and MIA models are equal in terms of clinically relevant pain behaviors, but the MIA model is associated with more severe histological changes over time potentially making it more suitable for screening disease modifying agents. Future work should further characterize each model in terms of complex pain behaviors and biochemical, molecular, and imaging analysis of the sensory system and joint tissues, which will allow for more informed decisions associated with model selection and investigative outcomes.

Activation of the kynurenine-aryl hydrocarbon receptor axis impairs the chondrogenic and chondroprotective effects of human umbilical cord-derived mesenchymal stromal cells in osteoarthritis rats.

It has been proven that intra-articular injection of mesenchymal stromal cells (MSCs) can alleviate cartilage damage in osteoarthritis (OA) by differentiating into chondrocytes and protecting inherent cartilage. However, the mechanism by which the OA articular microenvironment affects MSCs' therapeutic efficiency is yet to be fully elucidated. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor involved in various cellular processes, such as osteogenesis and immune regulation. Tryptophan (Trp) metabolites, most of which are endogenous ligand for AHR, are abnormally increased in synovial fluid (SF) of OA and rheumatoid arthritis (RA) patients. In this study, the effects of kynurenine (KYN), one of the most important metabolites of Trp, were evaluated on the chondrogenic and chondroprotective effects of human umbilical cord-derived mesenchymal stromal cells (hUC-MSCs). hUC-MSCs were cultured in conditioned medium containing different proportions of OA/RA SF, or stimulated with KYN directly, and then, AHR activation, proliferation, and chondrogenesis of hUC-MSCs were measured. Moreover, the chondroprotective efficiency of short hairpin-AHR-UC-MSC (shAHR-UC-MSC) was determined in a rat surgical OA model (right hind joint). OA SF could activate AHR signaling in hUC-MSCs in a concentration-dependent manner and inhibit the chondrogenic differentiation and proliferation ability of hUC-MSCs. Similar results were observed in hUC-MSCs stimulated with KYN in vitro. Notably, shAHR-UC-MSC exhibited superior therapeutic efficiency in OA rat upon intra-articular injection. Taken together, this study indicates that OA articular microenvironment is not conducive to the therapeutic effect of hUC-MSCs, which is related to the activation of the AHR pathway by tryptophan metabolites, and thus impairs the chondrogenic and chondroprotective effects of hUC-MSCs. AHR might be a promising modification target for further improving the therapeutic efficacy of hUC-MSCs on treatment of cartilage-related diseases such as OA.

Stabilization of hypoxia-inducible factor-1α alleviates osteoarthritis via interacting with Per2 and resetting the circadian clock

ObjectiveThe study aimed to establish whether HIF1α entrains the core clock in chondrocytes and how the HIF1α affects the circadian rhythm. MethodsWe subjected primary chondrocytes to chronic circadian desynchrony (CCD) and subsequently treated with oxygen rhythm and dimethyloxalylglycine (DMOG). Circadian oscillations were analyzed with a real-time monitoring system of Per2 promoter activity and qPCR. Chondrocytes were assayed core clock genes expression patterns and extracellular matrix metabolism. HIF1α siRNA was used to knock down HIF1α. ChIP-qPCR and dual-luciferase reporter assay were used to validate that Per2 was the target gene of HIF1α. The surgical model of osteoarthritis was induced by destabilization of the medial meniscus (DMM). The chronic jet lag model was established light/dark cycle advance shift. Joint degeneration was measured using histological staining, immunological assays, and micro-CT scanning. ResultsWe report that different patterns of clock genes expression between healthy and osteoarthritic cartilage tissues and oxygen rhythms and DMOG reset the molecular clockwork which was dampened after CCD culture in a HIF1α-dependent manner. HIF1α increased the amplitude of oscillation by directly binding to the HRE-like and E-box-like elements located on the Per2 promoter. The rhythmic circadian clock significantly enhanced extracellular matrix production. Our study also demonstrates that DMOG ameliorated the increased OA severity caused by jet lag in the DMM model. ConclusionsThis study shows that circadian clock resetting caused by DMOG is at least partially mediated by the HIF1α through interaction with the Per2 promoter and proposes DMOG as supportive therapy for OA.

Detection and Evaluation of Serological Biomarkers to Predict Osteoarthritis in Anterior Cruciate Ligament Transection Combined Medial Meniscectomy Rat Model.

Biomarkers are essential tools in osteoarthritis (OA) research, clinical trials, and drug development. Detecting and evaluating biomarkers in OA research can open new avenues for researching and developing new therapeutics. In the present report, we have explored the serological detection of various osteoarthritis-related biomarkers in the preclinical model of OA. In this surgical OA model, we disrupted the medial tibial cartilage’s integrity via anterior cruciate ligament transection combined with medial meniscectomy (ACLT+MMx) of a single joint of Wistar rats. The progression of OA was verified, as shown by the microscopic deterioration of cartilage and the increasing cartilage degeneration scoring from 4 to 12 weeks postsurgery. The concentration of serological biomarkers was measured at two timepoints, along with the complete blood count and bone electrolytes, with biochemical analysis further conducted. The panel evaluated inflammatory biomarkers, bone/cartilage biomarkers, and lipid metabolic pathway biomarkers. In chronic OA rats, we found a significant reduction of total vitamin D3 and C-telopeptide fragments of type II (CTX-II) levels in the serum as compared to sham-operated rats. In contrast, the serological levels of adiponectin, leptin, and matrix metallopeptidase (MMP3) were significantly enhanced in chronic OA rats. The inflammatory markers, blood cell composition, and biochemical profile remained unchanged after surgery. In conclusion, we found that a preclinical model of single-joint OA with significant deterioration of the cartilage can lead to serological changes to the cartilage and metabolic-related biomarkers without alteration of the systemic blood and biochemical profile. Thus, this biomarker profile provides a new tool for diagnostic/therapeutic assessment in OA scientific research.

Role of WNT Agonists, BMP and VEGF Antagonists in Rescuing Osteoarthritic Knee Cartilage in a Rat Model.

The superficial zone of articular cartilage (AC) is vital for its function and biomechanics. The damaged AC gets vascularized and undergoes hypertrophy and ossification. Studies have highlighted these two as the major causative factors in osteoarthritis (OA). We aimed at preventing the OA progression in a rat knee instability model by inhibiting the vascular ingrowth and ossification using VEGF and BMP antagonist. A WNT agonist was also used to promote AC regeneration because of its protective effect on the superficial layer. Rat knee OA was created by surgical excision of the medial meniscus and medial collateral ligament. Forty rats were divided into two groups of twenty each for surgical control and tests (surgery + intra-articular injection of drugs every two weeks). Ten animals from each group were sacrificed at four and eight weeks. Histology was mainly used to evaluate the outcome. A surgical OA model was successfully created with higher histological scores for operated knees, both in short- (P = 0.0001) and long-term (P = 0.001). Modified Mankin score was lesser in the test animals as compared to control (P = 0.17) in the short-term, but the trend was reversed in the long-term (P = 0.13). Subgroup analysis revealed that repeated injections in the anterolateral compartment contributed to higher scores in the lateral (P = 0.03) and anterior (P = 0.03) compartment of the knee in the long-term. The combinatorial approach was effective in controlling the OA in short-term. Further studies are needed to test the sustained drug delivery system to improve the outcome.

Refining surgical models of osteoarthritis in mice and rats alters pain phenotype but not joint pathology.

The relationship between osteoarthritis (OA) structural change and pain is complex. Surgical models of OA in rodents are often rapid in onset, limiting mechanistic utility and translational validity. We aimed to investigate the effect of refining surgical small rodent models of OA on both joint pathology and pain behaviour. Adult male C57BL/6 mice (n = 76, 10–11 weeks of age at time of surgery) underwent either traditional (transection of the medial meniscotibial ligament [MMTL]) or modified (MMTL left intact, transection of the coronary ligaments) DMM surgery, or sham surgery. Adult male Sprague Dawley rats (n = 76, weight 175-199g) underwent either modified meniscal transection (MMNX) surgery (transection of the medial meniscus whilst the medial collateral ligament is left intact) or sham surgery. Pain behaviours (weight bearing asymmetry [in mice and rats] and paw withdrawal thresholds [in rats]) were measured pre-surgery and weekly up to 16 weeks post-surgery. Post-mortem knee joints were scored for cartilage damage, synovitis, and osteophyte size. There was a significant increase in weight bearing asymmetry from 13 weeks following traditional, but not modified, DMM surgery when compared to sham operated mice. Both traditional and modified DMM surgery led to similar joint pathology. There was significant pain behaviour from 6 weeks following MMNX model compared to sham operated control rats. Synovitis was significant 4 weeks after MMNX surgery, whereas significant chondropathy was first evident 8 weeks post-surgery, compared to sham controls. Pain behaviour is not always present despite significant changes in medial tibial plateau cartilage damage and synovitis, reflecting the heterogeneity seen in human OA. The development of a slowly progressing surgical model of OA pain in the rat suggests that synovitis precedes pain behaviour and that chondropathy is evident later, providing the foundations for future mechanistic studies into the disease.

Histological scoring system for subchondral bone changes in murine models of joint aging and osteoarthritis

To establish a histopathological scoring system for changes in subchondral bone in murine models of knee osteoarthritis (OA), three key parameters, subchondral bone plate (Subcho.BP) consisting of the combination of Subcho.BP.thickness (Subcho.BP.Th) and angiogenesis, bone volume (BV/TV) and osteophytes, were selected. The new grading system was tested in two mouse OA models, (1) senescence accelerated mouse (SAM)-prone 8 (SAMP8) as spontaneous OA model with SAM-resistant 1 (SAMR1) as control; (2) destabilization of the medial meniscus in C57BL/6 mice as surgical OA model. Results of the spontaneous OA model showed that Subcho.BP.Th was significantly wider, angiogenesis was greater, and BV/TV was higher in SAMP8 than SAMR1. Notably, subchondral bone score was dramatically higher in SAMP8 at 6 weeks than SAMR1, while OARSI cartilage scores became higher only at 14 weeks. In the surgical OA model, the results were similar to the spontaneous OA model, but osteophytes appeared earlier. There were strong correlations both in Subcho.BP.Th and BV/TV between this scoring system and µCT (r = 0.89, 0.84, respectively). Inter-rater reliabilities for each parameter using this system were more than 0.943. We conclude that this new histopathological scoring system is readily applicable for evaluating the early changes in aging and OA-affected murine subchondral bone.

Indirect measures of autonomic nervous system function suggest vagal nerve sensitization in a surgical model of osteoarthritis

Purpose: A recent review entitled “The brain-joint axis in osteoarthritis: nerves, circadian clocks and beyond.” by Prof. Francis Berenbaum provides a framework for the contribution of the autonomic nervous system in OA. The autonomic nervous system is comprised of two branches, the parasympathetic (PNS) and sympathetic nervous systems (SNS), with reciprocal effects on involuntary actions throughout the body, such as heart rate, respiration, and digestion. In health, the PNS and SNS work together to balance these body functions, serving as an important regulator of immune system homeostasis and allostasis.

Targeting Extracellular miR-21-TLR7 Signaling Provides Long-Lasting Analgesia in Osteoarthritis

Osteoarthritis (OA) is the most prevalent joint disorder associated with severe chronic pain. Although synovial inflammation is well correlated with pain severity, the molecular mechanism responsible for OA pain remains unclear. Here, we show that extracellular miR-21 released from synovial tissue mediates knee OA pain in surgical OA model rats. miR-21 was the most abundant among increased microRNAs (miRNAs) in the synovial tissue. miR-21 was released into extracellular space from the synovial tissue and increased in the synovial fluid. A single intra-articular injection of miR-21 inhibitor exerted long-term analgesia of knee OA pain, whereas miR-21 injection in naive rats caused knee joint pain. miR-21 mutant, which lacks the Toll-like receptor (TLR) binding motif, but not in the seed sequence, did not cause joint pain, suggesting a non-canonical mode of action different from translational repression. Consistent with this, the algesic effect of miR-21 was blocked by antagonizing TLR7. The TLR7 antagonist also exerted a long-lasting analgesic effect on knee OA pain. Therefore, extracellular miR-21 released from synovial tissue mediates knee OA pain through TLR7 activation in surgical OA model rats. Extracellular miRNA in the joint may be a plausible target for pain therapy, providing a novel analgesic strategy for OA.

Inducible knockout of CHUK/IKK\u03b1 in adult chondrocytes reduces progression of cartilage degradation in a surgical model of osteoarthritis

CHUK/IKKα contributes to collagenase-driven extracellular matrix remodeling and chondrocyte hypertrophic differentiation in vitro, in a kinase-independent manner. These processes contribute to osteoarthritis (OA), where chondrocytes experience a phenotypic shift towards hypertrophy concomitant with abnormal matrix remodeling. Here we investigated the contribution of IKKα to OA in vivo. To this end, we induced specific IKKα knockout in adult chondrocytes in AcanCreERT2/+; IKKαf/f mice treated with tamoxifen (cKO). Vehicle-treated littermates were used as wild type controls (WT). At 12 weeks of age, WT and cKO mice were subjected to the destabilization of medial meniscus (DMM) model of post-traumatic OA. The cKO mice showed reduced cartilage degradation and collagenase activity and fewer hypertrophy-like features at 12 weeks after DMM. Interestingly, in spite of the protection from structural articular cartilage damage, the postnatal growth plates of IKKα cKO mice after DMM displayed abnormal architecture and composition associated with increased chondrocyte apoptosis, which were not as evident in the articular chondrocytes of the same animals. Together, our results provide evidence of a novel in vivo functional role for IKKα in cartilage degradation in post-traumatic OA, and also suggest intrinsic, cell-autonomous effects of IKKα in chondrocytes that control chondrocyte phenotype and impact on cell survival, matrix homeostasis, and remodeling.

Nociceptive neuroplasticity of the murine knee joint precedes severe structural joint damage in a surgical model of OA

Purpose: Surgical destabilization of the medial meniscus (DMM) in the mouse knee results in slowly progressive osteoarthritis (OA), characterized by mild-to-moderate joint damage by week 8 and severe damage by week 16 after surgery. Progressive joint damage is associated with pain-related behaviors. Using NaV1.8-tdTomato reporter mice, which express a bright red fluorescent tdTomato reporter in >90% of C-nociceptors (pain-sensing neurons), we recently reported that DMM surgery led to changes in the anatomical distribution of nociceptors in the medial compartment of the knee. Specifically, in association with severe structural joint damage 16 weeks after DMM, the medial compartment of OA knees showed increased NaV1.8+ innervation in the medial synovium and meniscus, and NaV1.8+ nociceptors in subchondral bone channels. Here, we analyzed the nociceptive innervation of the knee in the early stages of experimental OA, 4 and 8 weeks after DMM. Methods: DMM or sham surgery was performed in the right knee of 10-week old male C57BL/6 NaV1.8-tdTomato mice. Four and eight weeks after surgery, n=3 mice/group mice were perfused transcardially with paraformaldehyde, and the right knees collected, post fixed and decalcified. Twenty-μm thick coronal frozen sections were collected at mid-joint level, and imaged using a confocal microscope. NaV1.8-tdTomato signal of the medial synovium was quantified using ImageJ. Channels observed in the subchondral bone of the medial femoral condyles and tibial plateaux that contained NaV1.8+ nerves were quantified as follows: two mid-joint sections (80 μm apart) per knee were used to count NaV1.8+ channels; the counts were averaged for each knee. Results: As previously reported, 4 and 8 weeks after DMM surgery, cartilage damage in the femur and tibia was very mild and limited to slight loss of proteoglycans. In addition, DMM mice had maximal subchondral bone sclerosis in the medial compartment by week 4. Despite the limited cartilage damage at this stage, analysis of the NaV1.8+ signal showed striking changes in the nociceptive innervation after DMM surgery, compared to controls. Firstly, we detected an increase in NaV1.8 innervation of the medial synovium, as early as 4 weeks after DMM, and no further increase weeks 8-16 (Fig. 1). Secondly, NaV1.8+ nociceptors were observed in the subchondral bone pointing toward calcified cartilage, and this as early as week 4. Conclusions: These findings suggest that the NaV1.8 nociceptive innervation of the mouse knee changes very rapidly after DMM surgery, and this before the onset of significant joint damage. While the biological significance of this observation needs to be established, it suggests that neuroplasticity of sensory nerves is an early feature of OA joint damage, which may contribute to joint disease.

Chondrocyte specific expression of CCN2 does not modify osteoarthritis development in mice

Purpose: CCN2 is a matricellular protein which has been shown to be heavily involved in several complex biological processes including angiogenesis, fibrosis, and chondrogenesis. CCN2 is known to be expressed in both healthy and osteoarthritic cartilage, and involved in the production of the major cartilage matrix proteins; aggrecan and collagen type II. CCN2 null mice have been reported to exhibit a range of skeletal dysmorphisms, highlighting the importance of CCN2 in regulating matrix formation and turnover. The aim of this study was to determine the function of CCN2 in chondrocytes postnatally, in models of trauma-induced osteoarthritis (OA). Methods: Three double transgenic mouse models were generated; two inducible CCN2 knockout (KO) lines and one inducible CCN2 overexpressing (O/E) line. Both CCN2 KO lines contained Aggrecan CreERT2 enhancers which enabled the deletion of CCN2 from different populations of chondrocytes, whilst the O/E line contained an UbcCCN2-IRES-LacZ transgene enabling CCN2 O/E in all chondrocytes. CCN2 deletion and overexpression was induced following tamoxifen treatment in males aged 8 weeks. OA was induced either through surgical injury (transection of the medial meniscus and medial menisco-tibial ligament), or non-invasively by applying a controlled loading regimen to the tibio-femoral joint at 10 weeks of age. Knee joints were harvested and fixed, scanned with μCT, and processed for histology. Sections were stained with Toluidine Blue and scored for articular cartilage degeneration using the OARSI grading system. Results: In the surgical model of OA, cartilage degeneration was most severe on the medial side of the joint, however no significant differences were observed between lesion severity in wildtype (WT) and KO at any of the time-points analysed (2, 4, and, 8 weeks post-surgery). In the non-invasive model of OA lesion severity was most severe on the lateral femur in both the KO and O/E lines. As with the surgical model, no differences in lesion severity were observed between WT / KO and WT / O/E when analysed 6 weeks post-loading. μCT analysis of trabecular bone BV/TV and joint space in both models showed no effect of CCN2 KO and O/E between WT and experimental animals. Conclusions: CCN2 did not appear to play a protective role in the development of OA irrespective of whether the damage was induced surgically or non-invasively. The progression and severity of OA in both models, at all time-points, suggests the expression of CCN2 specifically in chondrocytes is not enough to protect articular cartilage from the degeneration associated with trauma-induced OA.

Discovery of Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists as Regulators of Chondrogenic Differentiation: Identification of Quinazolin-4(3 H)-ones and in Vivo Studies on a Surgically Induced Rat Model of Osteoarthritis.

Osteoarthritis (OA) is a degenerative disease characterized by joint destruction and loss of cartilage. There are many unmet needs in the treatment of OA and there are few promising candidates for disease-modifying OA drugs, particularly, anabolic agents. Here, we describe the identification of novel quinazolin-4(3 H)-one derivatives, which stimulate chondrocyte cartilage matrix production via TRPV4 and mitigate damaged articular cartilage. We successfully identified the water-soluble, highly potent quinazolin-4(3 H)-one derivative 36 and studied its intra-articular physicochemical profile to use in in vivo surgical OA model studies. Compound 36·HCl provided relief from OA damage in a rat medial meniscal tear (MT) model. Specifically, 36·HCl dose-dependently suppressed cartilage degradation and enhanced the messenger RNA expression of aggrecan and SOX9 in cartilage isolated from MT-operated rat knees compared with knees treated with vehicle. These results suggest that 36 induces anabolic changes in articular cartilage and consequently reduces OA progression.

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

BackgroundMIV-711 is a highly potent and selective cathepsin K inhibitor. The current article summarizes the therapeutic effects of MIV-711 on joint pathology in rabbits subjected to anterior cruciate ligament transection (ACLT), and the prophylactic effects on joint pathology in dogs subjected to partial medial meniscectomy, two surgical models of osteoarthritis (OA).MethodsStarting 1 week after surgery, rabbits were dosed daily via oral gavage with either MIV-711 or vehicle (n = 7/group) for 7 weeks. The four treatment groups were: (1) sham + vehicle; (2) ACLT + vehicle; (3) ACLT + MIV-711, 30 µmol/kg and (4) ACLT + MIV-711, 100 µmol/kg. Subchondral bone and articular cartilage structures were assessed by µCT, histomorphometry, and scoring. Dogs subjected to partial medial meniscectomy received either MIV-711 (30 µmol/kg) or vehicle (n = 15/group) via oral gavage once daily, starting 1 day before meniscectomy, for 28 days. Cartilage degradation was assessed at the macroscopic and microscopic levels. The exposures of MIV-711 were assessed in both studies and biomarkers reflecting bone resorption (HP-1 in rabbits, CTX-I in dogs) and cartilage degradation (CTX-II) were measured.ResultsIn ACLT rabbits, MIV-711 decreased HP-1 levels by up to 72% (p < 0.001) and CTX-II levels by up to 74% (p < 0.001) compared to ACLT vehicle controls. ACLT surgery significantly reduced the total thickness of the subchondral bone plate and reduced trabecular bone volume in the femur and tibia. These effects were reversed by MIV-711. ACLT resulted in cartilage thickening, which was attenuated by MIV-711. MIV-711 did not affect osteophyte formation or Mankin scores. In dogs, MIV-711 reduced CTX-I and CTX-II levels by 86% (p < 0.001) and 80% (p < 0.001), respectively. Synovial CTX-II levels were reduced by 55–57% (p < 0.001) compared to baseline. MIV-711-treated animals had 25–37% lower macroscopic scores in the femur condyles and 13–33% lower macroscopic scores in the tibial plateaus.ConclusionsMIV-711 prevents subchondral bone loss and partially attenuates cartilage pathology in two animal models of OA. These beneficial effects of MIV-711 on joint pathology are observed in conjunction with decreases in bone and cartilage biomarkers that have been shown to be clinically attainable in human. The data support the further development of MIV-711 for the treatment of OA.

ELF3 contributes to cartilage degradation by controlling the expression of MMP13 in vivo, in a surgical model of osteoarthritis in mice

ELF3 contributes to cartilage degradation by controlling the expression of MMP13 in vivo, in a surgical model of osteoarthritis in mice

The role of tetraspanin CD9 in osteoarthritis using three different mouse models.

Although osteoarthritis (OA) is the most prevalent aging-related joint disease, the understanding of mechanisms of OA pathogenesis remains limited. Key features include the progressive degradation of articular cartilage, synovial hyperplasia, and angiogenesis in joint tissues. CD9, a member of the tetraspanin family, is localized in the cell membranes and partly in the endosomes of all mammalian cell types. CD9 is associated with inflammation and angiogenesis through cell adhesion, migration, and signal transduction. This study examined the role of CD9 in OA development in three different mouse models: an aging model, a surgical model and antigen-induced arthritis (AIA) model, using CD9 deficient mice. Our study showed that CD9 deficiency reduced the severity of hallmarks of OA including cartilage degradation and soft tissue inflammation in aged mice. In the AIA model, cartilage damage and inflammation were also reduced in CD9-/- mice. This was in contrast to the surgical OA model where disease severity was similar in wild-type and CD9-/- mice. Col2a1 and Aggrecan expression was increased in chondrocytes of CD9-/- mice compared with those of wild-type mice. Our results indicate that the suppression of cartilage degradation in CD9-/- could be in part related to an increase in the expression of the two main cartilage extracellular matrix proteins aggrecan and type II collagen.

Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.

A disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4) and ADAMTS-5 are zinc metalloproteases commonly referred to as aggrecanase-1 and aggrecanase-2, respectively. These enzymes are involved in the degradation of aggrecan, a key component of cartilage. Inhibitors of these enzymes could be potential osteoarthritis (OA) therapies. A series of hydantoin inhibitors of ADAMTS-4 and ADAMTS-5 were identified from a screening campaign and optimized through structure-based drug design to give hydantoin 13. Hydantoin 13 had excellent selectivity over other zinc metalloproteases such as TACE, MMP2, MMP3, MMP13, and MMP14. The compound also produced efficacy in both a chemically induced and surgical model of OA in rats.

Effect of S-methylisothiourea, an inducible nitric oxide synthase inhibitor, in joint pain and pathology in surgically induced model of osteoarthritis

The aim of the present study was to evaluate in vivo modulatory effect of S-methylisothiourea (SMT), a preferential inhibitor of inducible nitric oxide synthase (iNOS) on pain and pathology in the surgical model of osteoarthritis (OA) in rats. The OA was produced by the anterior cruciate ligament transection (ACLT) and medial meniscectomy (MMx) of right knee. SMT was administered 1 day prior to the production of OA and continued up to day 42 postoperation. Mechanical hyperalgesia, thermal hyperalgesia, tail flick latency after repeated flexion and extension of OA knee and knee diameter of right knee were determined at weekly intervals. Serum levels of IL-1β, TNF-α and nitrite concentration were determined at the end of the experiment. Glycosaminoglycan (GAG) content, collagen content and histopathological evaluation of articular cartilage were also determined at the end of the experiment. SMT reduced mechanical hyperalgesia and the serum levels of IL-1β, TNF-α and nitrite. Further, SMT reduced the loss of GAG from articular cartilage. Microscopically, SMT reduced the severity of the cartilage lesion. The results indicate the effectiveness of SMT in attenuating the pain and pathology of experimental OA phase by reducing the production of nitric oxide and interleukin-1β and tumor necrosis factor-α, which are known to play a major role in the pathophysiology of OA.

In vivo imaging of MMP-13 activity in the murine destabilised medial meniscus surgical model of osteoarthritis

To detect and determine disease severity of osteoarthritis (OA) using a probe activated by matrix metalloproteinase-13 (MMP-13) invivo in the murine destabilised medial meniscus (DMM) surgical model of OA. We have previously described MMP12ap and MMP13ap, internally quenched fluorescent peptide substrate probes that are activated respectively by MMP-12 and MMP-13. Here we used these probes to follow enzyme activity invivo in mice knees 4, 6 and 8 weeks following DMM surgery. After invivo optical imaging, disease severity was determined through traditional histological analysis. The amount of probe activation was analysed for discrimination between DMM, contralateral and sham operated knees, as well as for congruence between activity and histological damage. There was no specific activation of MMP12ap at the time points observed between sham operated and DMM operated, or their respective contralateral joints. The activation of the MMP13ap in the DMM model was highest 6 weeks after surgery, but was only specific compared against sham surgery 8 weeks after surgery (1.5-fold increase). The activation of MMP13ap correlated with histological damage 6 and 8 weeks after surgery, with correlations of 0.484 (P=0.0032) and 0.478 respectively (P=0.0049). This correlation dropped to 0.218 (P=0.011) if all data were considered. The current MMP-13 activity probe is suitable for the discrimination between DMM and sham or contralateral knees 8 weeks after surgery, when cartilage loss is typified by the appearance of small fissures up to the tidemark, but not earlier. This activity correlates with the histological damage observed.

The role of tetraspanin Cd9 in pathogenesis of osteoarthritis

Purpose: Osteoarthritis (OA) is a chronic and highly prevalent joint disease, and it is whole-joint disorder that is characterized by progressive degeneration of articular cartilage, synovial hyperplasia and angiogenesis as a result of excessive mechanical load or inflammation in various joint tissues. Therefore, understanding the molecular mechanisms that maintain whole-joint health has been required. Recently, it is reported that tetraspanin CD9 expression in OA synovium is upregulated. However, the role of CD9 in OA pathogenesis is still unclear. We hypothesize that CD9 may play an important role in OA pathogenesis. In order to propose a new concept of OA pathogenesis, we examined histopathological changes in knee joints using experimentally OA-induced models in CD9 KO mice. The purpose of this study is to examine the role of tetraspanine CD9 in OA pathogenesis. Methods: To reveal whether CD9 KO mice exhibit onset of OA-like changes during aging, we examined histology of knee joint using 1M-, 3M-, 6M-, and 12M-old mice. We also examined the expression of cartilage-related genes in articular chondrocytes from 1M-old mice. Next, to examine OA pathogenesis in CD9 KO mice, we generated two arthritis models, an antigen-induced-arthritis (AIA) model and a surgical model in knee joint. Inflammatory arthritis was induced in knee joint of 10-week-old wild-type (WT) and CD9 KO mice by intra-articular injection of methylated bovine serum albumin (mBSA) in mice preimmunized with mBSA and adjuvant. 7 days after intra-articular injection, the knee joints were harvested and processed. The AIA model in WT and CD9 KO mice were evaluated using inflammatory score consisted of 5 parameters which are synovitis, joint space exudate, soft tissue inflammation, cartilage degradation and bone damage. The surgical OA model was induced by resecting the medial meniscotibial ligament (MMTL) of 12-week-old WT and CD9KO mice. Pathological OA-like changes in medial femoral condyle (MFC) and medial tibial plateau (MTP) were evaluated 12 weeks after resecting MMTL on safranin-O-stained sections using Osteoarthritis Research Society International (OARSI) score. Results: The knee joints of 1M-, 3M- 6M-, and 12M-old CD9 KO mice were not showed early onset OA-like changes in their knee joints compared with WT mice and their development appeared normal. The expressions of cartilage-related genes in chondrocytes from CD9 KO were not significantly difference compared with chondrocytes from WT. In AIA model, inflammation in CD9 KO mice was suppressed and inflammation score of them was significantly lower in all 5 parameters and total score. In surgical model, no significant change was observed in the OARSI score of MFC between the WT and CD9 KO mice. However, we detected significantly suppressed OA-like pathological changes in the MTP in the CD9 KO mice compared with those in the WT mice. Conclusions: Inflammation and OA-like pathological changes are suppressed in tetraspanin CD9 KO mice compared with those in WT mice. Our results indicate that CD9 accelerates the development of OA. Recently, it was reported that exosomes, a new paracrine factor for cell-cell communication were decreased in CD9 KO mice because exosomes consist of several members of the tetraspanin family including CD9. Our studies might have the potential to open new insights on OA mechanisms.